Guideline Summary for Patients and Their Families
This acute migraine treatment guideline is summarized here to provide information for patients with migraine and their families. Acute migraine medications are used to treat individual migraine attacks at the time of the attack. Most patients with migraine will use an acute medication, but patients...
Gespeichert in:
Veröffentlicht in: | Canadian journal of neurological sciences 2013-09, Vol.40 (S3), p.S69-S72 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S72 |
---|---|
container_issue | S3 |
container_start_page | S69 |
container_title | Canadian journal of neurological sciences |
container_volume | 40 |
creator | Becker, Werner J. Worthington, Irene |
description | This acute migraine treatment guideline is summarized here to provide information for patients with migraine and their families. Acute migraine medications are used to treat individual migraine attacks at the time of the attack. Most patients with migraine will use an acute medication, but patients with migraine, especially if they have frequent attacks, should also consider whether they could change lifestyle factors which might be making their headache more frequent (skipping meals, not enough sleep, etc), or whether they need a migraine preventive medication. Preventive (or prophylactic) medications are quite different from acute medications. Preventive medications are taken daily to reduce the frequency (number) of migraine attacks, while acute medications are used to reduce or stop the pain of a migraine attack once it has started. It is important that acute medications not be taken too often. |
doi_str_mv | 10.1017/S0317167100118992 |
format | Article |
fullrecord | <record><control><sourceid>cambridge_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1017_S0317167100118992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0317167100118992</cupid><sourcerecordid>10_1017_S0317167100118992</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1992-e723be1acdd4f29d7a7ec810579f09625fed9cc80b1ea5e640174f0ce02006ab3</originalsourceid><addsrcrecordid>eNp9j0FOwzAQRS0EEqFwAHa5QGDGie14iSpaKlUCqWUdOfYYXCUpspsFtycR3SGxmsXX__MeY_cIDwioHndQokKpEACx1ppfsIyDUAWgEJcsm-Nizq_ZTUoHAC6FrDKG6zE46sJA-W7sexO_c3-M-Zs5BRpOKTeDy_efFGK-Mn3oAqVbduVNl-jufBfsffW8X74U29f1Zvm0LSxO7wtSvGwJjXWu8lw7ZRTZGick7UFLLjw5bW0NLZIRJKvJovJgCTiANG25YPi7a-MxpUi--YphBmwQmtm5-eM8dcpzx_RtDO6DmsNxjMPE-U_rB-fpV94</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Guideline Summary for Patients and Their Families</title><source>Cambridge University Press Journals Complete</source><creator>Becker, Werner J. ; Worthington, Irene</creator><creatorcontrib>Becker, Werner J. ; Worthington, Irene ; on behalf of the Canadian Headache Society Acute Migraine Treatment Guideline Development Group</creatorcontrib><description>This acute migraine treatment guideline is summarized here to provide information for patients with migraine and their families. Acute migraine medications are used to treat individual migraine attacks at the time of the attack. Most patients with migraine will use an acute medication, but patients with migraine, especially if they have frequent attacks, should also consider whether they could change lifestyle factors which might be making their headache more frequent (skipping meals, not enough sleep, etc), or whether they need a migraine preventive medication. Preventive (or prophylactic) medications are quite different from acute medications. Preventive medications are taken daily to reduce the frequency (number) of migraine attacks, while acute medications are used to reduce or stop the pain of a migraine attack once it has started. It is important that acute medications not be taken too often.</description><identifier>ISSN: 0317-1671</identifier><identifier>EISSN: 2057-0155</identifier><identifier>DOI: 10.1017/S0317167100118992</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>SECTION V</subject><ispartof>Canadian journal of neurological sciences, 2013-09, Vol.40 (S3), p.S69-S72</ispartof><rights>Copyright © The Canadian Journal of Neurological 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0317167100118992/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,315,782,786,27933,27934,55637</link.rule.ids></links><search><creatorcontrib>Becker, Werner J.</creatorcontrib><creatorcontrib>Worthington, Irene</creatorcontrib><creatorcontrib>on behalf of the Canadian Headache Society Acute Migraine Treatment Guideline Development Group</creatorcontrib><title>Guideline Summary for Patients and Their Families</title><title>Canadian journal of neurological sciences</title><addtitle>Can. J. Neurol. Sci</addtitle><description>This acute migraine treatment guideline is summarized here to provide information for patients with migraine and their families. Acute migraine medications are used to treat individual migraine attacks at the time of the attack. Most patients with migraine will use an acute medication, but patients with migraine, especially if they have frequent attacks, should also consider whether they could change lifestyle factors which might be making their headache more frequent (skipping meals, not enough sleep, etc), or whether they need a migraine preventive medication. Preventive (or prophylactic) medications are quite different from acute medications. Preventive medications are taken daily to reduce the frequency (number) of migraine attacks, while acute medications are used to reduce or stop the pain of a migraine attack once it has started. It is important that acute medications not be taken too often.</description><subject>SECTION V</subject><issn>0317-1671</issn><issn>2057-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9j0FOwzAQRS0EEqFwAHa5QGDGie14iSpaKlUCqWUdOfYYXCUpspsFtycR3SGxmsXX__MeY_cIDwioHndQokKpEACx1ppfsIyDUAWgEJcsm-Nizq_ZTUoHAC6FrDKG6zE46sJA-W7sexO_c3-M-Zs5BRpOKTeDy_efFGK-Mn3oAqVbduVNl-jufBfsffW8X74U29f1Zvm0LSxO7wtSvGwJjXWu8lw7ZRTZGick7UFLLjw5bW0NLZIRJKvJovJgCTiANG25YPi7a-MxpUi--YphBmwQmtm5-eM8dcpzx_RtDO6DmsNxjMPE-U_rB-fpV94</recordid><startdate>201309</startdate><enddate>201309</enddate><creator>Becker, Werner J.</creator><creator>Worthington, Irene</creator><general>Cambridge University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201309</creationdate><title>Guideline Summary for Patients and Their Families</title><author>Becker, Werner J. ; Worthington, Irene</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1992-e723be1acdd4f29d7a7ec810579f09625fed9cc80b1ea5e640174f0ce02006ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>SECTION V</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Becker, Werner J.</creatorcontrib><creatorcontrib>Worthington, Irene</creatorcontrib><creatorcontrib>on behalf of the Canadian Headache Society Acute Migraine Treatment Guideline Development Group</creatorcontrib><collection>CrossRef</collection><jtitle>Canadian journal of neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Becker, Werner J.</au><au>Worthington, Irene</au><aucorp>on behalf of the Canadian Headache Society Acute Migraine Treatment Guideline Development Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Guideline Summary for Patients and Their Families</atitle><jtitle>Canadian journal of neurological sciences</jtitle><addtitle>Can. J. Neurol. Sci</addtitle><date>2013-09</date><risdate>2013</risdate><volume>40</volume><issue>S3</issue><spage>S69</spage><epage>S72</epage><pages>S69-S72</pages><issn>0317-1671</issn><eissn>2057-0155</eissn><abstract>This acute migraine treatment guideline is summarized here to provide information for patients with migraine and their families. Acute migraine medications are used to treat individual migraine attacks at the time of the attack. Most patients with migraine will use an acute medication, but patients with migraine, especially if they have frequent attacks, should also consider whether they could change lifestyle factors which might be making their headache more frequent (skipping meals, not enough sleep, etc), or whether they need a migraine preventive medication. Preventive (or prophylactic) medications are quite different from acute medications. Preventive medications are taken daily to reduce the frequency (number) of migraine attacks, while acute medications are used to reduce or stop the pain of a migraine attack once it has started. It is important that acute medications not be taken too often.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><doi>10.1017/S0317167100118992</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0317-1671 |
ispartof | Canadian journal of neurological sciences, 2013-09, Vol.40 (S3), p.S69-S72 |
issn | 0317-1671 2057-0155 |
language | eng |
recordid | cdi_crossref_primary_10_1017_S0317167100118992 |
source | Cambridge University Press Journals Complete |
subjects | SECTION V |
title | Guideline Summary for Patients and Their Families |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T13%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-cambridge_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Guideline%20Summary%20for%20Patients%20and%20Their%20Families&rft.jtitle=Canadian%20journal%20of%20neurological%20sciences&rft.au=Becker,%20Werner%20J.&rft.aucorp=on%20behalf%20of%20the%20Canadian%20Headache%20Society%20Acute%20Migraine%20Treatment%20Guideline%20Development%20Group&rft.date=2013-09&rft.volume=40&rft.issue=S3&rft.spage=S69&rft.epage=S72&rft.pages=S69-S72&rft.issn=0317-1671&rft.eissn=2057-0155&rft_id=info:doi/10.1017/S0317167100118992&rft_dat=%3Ccambridge_cross%3E10_1017_S0317167100118992%3C/cambridge_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_cupid=10_1017_S0317167100118992&rfr_iscdi=true |